Picture Name

HUAREN MEDICAL TECHNOLOGY

NEWS

21

2022-05

Negotiate Cooperation // Guangxi Huaren Medical Technology Group Leaders Go to Huaiyang District, Zhoukou City to Attend Project Matchmaking Meeting


On the afternoon of May 15, 2022, the docking meeting of the innovative biomedical industrial park project of Huaiyang District, Zhoukou City was held in the Standing Committee Room on the third floor of the District Committee. Zhoukou Huaiyang District Party Committee Secretary Zhang Jiandang and other leaders and Guangxi Huaren Medical Science and Technology Group President Ji Feng attended the meeting.

View More

21

2022-05

The first Open Day of "Guangxi Academy of Sciences Institute of Medicine and Health" Laboratory was successfully held!


On May 20, 2022, the first "Open Day" activity was successfully held in the laboratory of Guangxi Academy of Sciences Institute of Medicine and Health, which is located in Building 3, Phase II, Big Data Industrial Park, No. 9, Haihui Road, Nanning Area, China (Guangxi) Pilot Free Trade Zone.

View More

13

2022-05

Mesenchymal stem cells combined with filipin protein bioscaffolds - a new hope for tendon repair!


Tendons transmit force from muscle to bone and are an important connective tissue in the human body. Often the mention of tendon injuries brings a big frown to people's faces: in most people's perception, the first time they probably learnt about tendon injuries was at the 2008 Olympic Games in China, when the Chinese athlete Liu Xiang regrettably retired because of a ruptured Achilles tendon.

View More

08

2022-05

Tumour-infiltrating T cells possess special access to the interior of the tumour


Immune checkpoint blockade therapy is a treatment that has the potential to completely cure cancer, and although this intervention has shown considerable efficacy in patients with metastatic melanoma, clinical efficacy remains low for most other cancers, a condition that is associated with tumours and lymphocytes, including stem-cell-like tumour-infiltrating T-cells as well as T-cells that express inhibitory receptors (e.g. PD-1).

View More

08

2022-05

Cancer Cell: Inflammatory fibroblasts reduce radiotherapy sensitivity in rectal cancer


Colorectal cancer is one of the most common cancers worldwide and has the second highest mortality rate among malignant tumours. Treatment options for patients with colorectal cancer include surgery, chemotherapy, radiotherapy and other molecularly targeted strategies that significantly prolong patient survival. Among colorectal cancers, rectal cancers have a worse prognosis than colon cancers in terms of both metastasis formation and local recurrence.

View More

26

2022-04

[Lianhua Plague Dispute] - Please let science return to science.


For a long time, Shanghai for many consecutive days, the number of new new crown pneumonia infections over 10,000, the main epidemic strain of this outbreak is omikujon BA.2, has a fast transmission speed, invisibility, asymptomatic and a high proportion of mild symptoms, based on the population density of Shanghai, the difficulty of prevention and control is much higher than ever before.

View More
< 1...141516...22 >